Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis

被引:79
作者
Frey, Melissa K. [1 ,6 ]
Ahsan, Muhammad Danyal [1 ]
Bergeron, Hannah [1 ]
Lin, Jenny [1 ]
Li, Xuan [1 ]
Fowlkes, Rana K. [1 ]
Narayan, Priyanka [1 ]
Nitecki, Roni [2 ]
Rauh-Hain, Jose Alejandro [2 ]
Moss, Haley A. [3 ]
Baltich Nelson, Becky [1 ]
Thomas, Charlene [1 ]
Christos, Paul J. [1 ]
Hamilton, Jada G. [4 ]
Chapman-Davis, Eloise [1 ]
Cantillo, Evelyn [1 ]
Holcomb, Kevin [1 ]
Kurian, Allison W. [5 ]
Lipkin, Steven [1 ]
Offit, Kenneth [4 ]
Sharaf, Ravi N. [1 ]
机构
[1] Weill Cornell Med, New York, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Memorial Sloan Kettering Canc Ctr, New York, NY USA
[5] Stanford Univ, Sch Med, Palo Alto, CA USA
[6] Weill Cornell Med, Div Gynecol Oncol, 525 East 68th St,Suite J 130, New York, NY 10065 USA
关键词
NONPOLYPOSIS COLORECTAL-CANCER; BRCA MUTATION CARRIERS; BREAST-OVARIAN CANCER; LYNCH-SYNDROME; FAMILY COMMUNICATION; GENETIC INFORMATION; UPTAKE RATES; RISK; DISCLOSURE; WOMEN;
D O I
10.1200/JCO.22.00303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEEvidence-based guidelines recommend cascade genetic counseling and testing for hereditary cancer syndromes, providing relatives the opportunity for early detection and prevention of cancer. The current standard is for patients to contact and encourage relatives (patient-mediated contact) to undergo counseling and testing. Direct relative contact by the medical team or testing laboratory has shown promise but is complicated by privacy laws and lack of infrastructure. We sought to compare outcomes associated with patient-mediated and direct relative contact for hereditary cancer cascade genetic counseling and testing in the first meta-analysis on this topic.MATERIALS AND METHODSWe conducted a systematic review and meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO No.: CRD42020134276). We searched key electronic databases to identify studies evaluating hereditary cancer cascade testing. Eligible trials were subjected to meta-analysis.RESULTSEighty-seven studies met inclusion criteria. Among relatives included in the meta-analysis, 48% (95% CI, 38 to 58) underwent cascade genetic counseling and 41% (95% CI, 34 to 48) cascade genetic testing. Compared with the patient-mediated approach, direct relative contact resulted in significantly higher uptake of genetic counseling for all relatives (63% [95% CI, 49 to 75] v 35% [95% CI, 24 to 48]) and genetic testing for first-degree relatives (62% [95% CI, 49 to 73] v 40% [95% CI, 32 to 48]). Methods of direct contact included telephone calls, letters, and e-mails; respective rates of genetic testing completion were 61% (95% CI, 51 to 70), 48% (95% CI, 37 to 59), and 48% (95% CI, 45 to 50).CONCLUSIONMost relatives at risk for hereditary cancer do not undergo cascade genetic counseling and testing, forgoing potentially life-saving medical interventions. Compared with patient-mediated contact, direct relative contact increased rates of cascade genetic counseling and testing, arguing for a shift in the care delivery paradigm, to be confirmed by randomized controlled trials.
引用
收藏
页码:4129 / +
页数:31
相关论文
共 138 条
[61]  
2-J
[62]   Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing? [J].
Hall, Evan T. ;
Parikh, Divya ;
Caswell-Jin, Jennifer L. ;
Gupta, Tanya ;
Mills, Meredith A. ;
Kingham, Kerry E. ;
Koff, Rachel ;
Ford, James M. ;
Kurian, Allison W. .
JCO PRECISION ONCOLOGY, 2018, 2 :1-10
[63]  
Hallowell N, 2005, J Genet Couns, V14, P207, DOI 10.1007/s10897-005-0384-3
[64]   Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling [J].
Hayden, Sommer ;
Mange, Sarah ;
Duquette, Debra ;
Petrucelli, Nancie ;
Raymond, Victoria M. .
JOURNAL OF GENETIC COUNSELING, 2017, 26 (04) :859-865
[65]   Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families [J].
Healey, Emma ;
Taylor, Natalie ;
Greening, Sian ;
Wakefield, Claire E. ;
Warwick, Linda ;
Williams, Rachel ;
Tucker, Kathy .
GENETICS IN MEDICINE, 2017, 19 (12) :1323-1331
[66]   What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing? [J].
Henrikson, Nora B. ;
Wagner, Jennifer K. ;
Hampel, Heather ;
DeVore, Christopher ;
Shridhar, Nirupama ;
Williams, Janet L. ;
Donohue, Katherine E. ;
Kullo, Iftikhar ;
Prince, Anya E. R. .
JOURNAL OF LAW AND THE BIOSCIENCES, 2021, 7 (01)
[67]   Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening [J].
Henrikson, Nora B. ;
Blasi, Paula ;
Figueroa Gray, Marlaine ;
Tiffany, Brooks T. ;
Scrol, Aaron ;
Ralston, James D. ;
Fullerton, Stephanie M. ;
Lim, Catherine Y. ;
Ewing, John ;
Leppig, Kathleen A. .
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06)
[68]   Uptake of testing for BRCA1/2 mutations in South East Scotland [J].
Holloway, Susan M. ;
Bernhard, Birgitta ;
Campbell, Harry ;
Lam, Wayne W. K. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (08) :906-912
[69]   All in the family:: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results [J].
Hughes, C ;
Lerman, C ;
Schwartz, M ;
Peshkin, BN ;
Wenzel, L ;
Narod, S ;
Corio, C ;
Tercyak, KP ;
Hanna, D ;
Isaacs, C ;
Main, D .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 107 (02) :143-150
[70]   Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk [J].
Idos, Gregory E. ;
Kurian, Allison W. ;
Ricker, Charite ;
Sturgeon, Duveen ;
Culver, Julie O. ;
Kingham, Kerry E. ;
Koff, Rachel ;
Chun, Nicolette M. ;
Rowe-Teeter, Courtney ;
Lebensohn, Alexandra P. ;
Levonian, Peter ;
Lowstuter, Katrina ;
Partynski, Katlyn ;
Hong, Christine ;
Mills, Meredith A. ;
Petrovchich, Iva ;
Ma, Cindy S. ;
Hartman, Anne-Renee ;
Allen, Brian ;
Wenstrup, Richard J. ;
Lancaster, Johnathan M. ;
Brown, Krystal ;
Kidd, John ;
Evans, Brent ;
Mukherjee, Bhramar ;
McDonnell, Kevin J. ;
Ladabaum, Uri ;
Ford, James M. ;
Gruber, Stephen B. .
JCO PRECISION ONCOLOGY, 2019, 3 :1-12